文献速递系统性红斑狼疮其他结缔组织病

干扰素阳性的系统性红斑狼疮和抗磷脂综合征中浆细胞样树突状细胞微小RNA表达下调

microRNA downregulation in plasmacytoid dendritic cells in interferon-positive systemic lupus erythematosus and antiphospholipid syndrome.
PubMed 文献 · Rheumatology (Oxford) · 2018-01-01

研究检测了系统性红斑狼疮(SLE)、SLE合并抗磷脂综合征(APS)及原发性APS患者浆细胞样树突状细胞(pDC)中微小RNA(miRNA)与mRNA表达,发现三组患者均有miRNA表达下调且与干扰素特征相关,TLR7激活可诱导类似下调模式。

要点

  • 在pDC检测到的131个miRNA中,SLE、SLE+APS和PAPS分别有35、17和21个表达显著低于健康对照。
  • SLE与APS的miRNA谱无显著差异,主要由干扰素特征的存在与否驱动。
  • TLR7刺激诱导miRNA普遍下调,与SLE和APS患者中观察到的模式相似。

核心结论

  • SLE、SLE+APS和PAPS患者pDC中miRNA表达降低是共有的,且与干扰素特征相关。
  • 作者认为更好地理解导致pDC失调的分子机制/通路可能为治疗干预开辟新途径。

研究设计与样本

  • 采用OpenArray和RNA测序测量SLE、SLE+APS(继发于SLE的APS)和原发性APS(PAPS)患者pDC的miRNA和mRNA表达。
  • 将患者miRNA谱与TLR7激活的pDC的miRNA模式进行比较。

主要发现

  • 在pDC检测到的131个miRNA中,SLE、SLE+APS和PAPS患者分别有35、17和21个表达显著低于健康对照(HC)。
  • SLE与APS之间的miRNA谱无显著差异,但由干扰素特征的存在或缺失驱动。
  • TLR7刺激诱导miRNA普遍下调,与SLE和APS患者中观察到的模式相似。
  • 与低干扰素特征患者和HC相比,高干扰素特征患者中miR-361-5p、miR-128-3p和miR-181a-2-3p表达较低(错误发现率<0.05)。
  • 对miRNA靶标与RNAseq上调基因重叠部分的通路富集分析表明,这些miRNA参与pDC活化和凋亡。

关键数值与推荐

  • 在pDC检测到的131个miRNA中,SLE、SLE+APS和PAPS分别有35、17和21个表达显著低于HC。
  • 高干扰素特征患者中miR-361-5p、miR-128-3p和miR-181a-2-3p表达低于低干扰素特征患者和HC(错误发现率<0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate miRNA expression in relation to transcriptomic changes in plasmacytoid dendritic cells (pDCs) in SLE and APS. pDCs are major producers of IFNα in SLE and APS, and miRNAs are emerging as regulators of pDC activation. METHODS: miRNA and mRNA expression were measured by OpenArray and RNA-sequencing in pDCs of SLE, SLE + APS (APS secondary to SLE) and primary APS (PAPS) patients. The miRNA profile of patients was compared with the miRNA pattern of TLR7-activated pDCs. RESULTS: Among 131 miRNAs detected in pDCs, 35, 17 and 21 had a significantly lower level of expression in SLE, SLE + APS and PAPS patients, respectively, as compared with healthy controls (HC). Notably, the miRNA profile did not significantly differ between SLE and APS, but was driven by the presence or absence of an IFN signature. TLR7 stimulation induced a general downregulation of miRNAs, similar to the pattern observed in SLE and APS patients. miR-361-5p, miR-128-3p and miR-181a-2-3p expression was lower in patients with a high IFN signature (false discovery rate <0.05) as compared with patients with a low IFN signature and HCs. Pathway enrichment on the overlap of miRNA targets and upregulated genes from the RNAseq indicated that these miRNAs are involved in pDC activation and apoptosis. CONCLUSION: Lower miRNA expression in pDCs is shared between SLE, SLE + APS and PAPS and is related to the IFN signature. As pDCs are the alleged source of the IFN signature in these patients, a better understanding of the molecular mechanisms/pathways leading to pDC dysregulation in SLE and APS might open novel pathways for therapeutic intervention.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. van den Hoogen LL, Rossato M, Lopes AP, et al. microRNA downregulation in plasmacytoid dendritic cells in interferon-positive systemic lupus erythematosus and antiphospholipid syndrome. Rheumatology (Oxford). 2018. PMID: 29873766. doi:10.1093/rheumatology/key159

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。